BioLineRx (BLRX) EBIAT (2013 - 2025)
BioLineRx (BLRX) posted EBIAT of -$2.2 million for Q4 2025, down 128.86% on a QoQ basis from -$977000.0 in Q3 2025, and up 29.84% year-over-year from -$1.7 million in Q4 2024.
BioLineRx (BLRX) has 13 years of EBIAT data on file, last reported at -$2.2 million in Q4 2025.
- In Q4 2025, EBIAT rose 29.84% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at $5.9 million (up 163.49% YoY), while the FY2025 annual figure was -$2.0 million, up 78.03% from the prior year.
- EBIAT slipped to -$2.2 million in Q4 2025, from -$977000.0 in the prior quarter.
- Across five years, EBIAT topped out at $18.5 million in Q2 2023 and bottomed at -$16.0 million in Q3 2023.
- A 5-year average of -$2.5 million and a median of -$3.7 million in 2021 frame the typical range for EBIAT.
- Annual changes were most pronounced in 2023 — EBIAT tumbled 146.69% — and 2025, when it jumped 836.64%.
- Year by year, EBIAT stood at -$4.3 million in 2021, then sank by 33.16% to -$5.7 million in 2022, then plunged by 142.26% to -$13.9 million in 2023, then jumped by 77.05% to -$3.2 million in 2024, then climbed by 29.84% to -$2.2 million in 2025.
- The last three EBIAT figures came in at -$2.2 million (Q4 2025), -$977000.0 (Q3 2025), and $3.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -977,000.00 |
| Jun 30, 2025 | 3.94 Mn |
| Mar 31, 2025 | 5.13 Mn |
| Dec 31, 2024 | -3.19 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | -696,000.00 |
| Dec 31, 2023 | -13.88 Mn |
| Sep 30, 2023 | -16.02 Mn |
| Jun 30, 2023 | 18.55 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -5.73 Mn |
| Sep 30, 2022 | -6.85 Mn |
| Jun 30, 2022 | 7.44 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Sep 30, 2021 | -5.72 Mn |
| Jun 30, 2021 | 6.84 Mn |
| Mar 31, 2021 | -10.19 Mn |
| Dec 31, 2020 | -11.99 Mn |
| Sep 30, 2020 | -4.62 Mn |
| Jun 30, 2020 | 6.77 Mn |
| Mar 31, 2020 | -6.65 Mn |
| Dec 31, 2019 | -9.87 Mn |
| Sep 30, 2019 | -3.94 Mn |
| Jun 30, 2019 | 5.49 Mn |
| Mar 31, 2019 | -6.16 Mn |
| Dec 31, 2018 | -5.65 Mn |
| Sep 30, 2018 | -6.32 Mn |
| Jun 30, 2018 | 4.79 Mn |
| Mar 31, 2018 | -6.20 Mn |
| Dec 31, 2017 | -7.36 Mn |
| Sep 30, 2017 | -7.24 Mn |
| Jun 30, 2017 | 4.90 Mn |
| Mar 31, 2017 | -4.86 Mn |
| Dec 31, 2016 | -4.29 Mn |
| Sep 30, 2016 | -4.33 Mn |
| Jun 30, 2016 | -3.74 Mn |
| Mar 31, 2016 | -3.49 Mn |
| Dec 31, 2015 | -3.65 Mn |
| Sep 30, 2015 | -1.63 Mn |
| Jun 30, 2015 | -4.81 Mn |
| Mar 31, 2015 | -4.31 Mn |
| Dec 31, 2014 | -4.19 Mn |
| Sep 30, 2014 | -700,000.00 |
| Jun 30, 2014 | -4.07 Mn |
| Mar 31, 2014 | -2.12 Mn |
| Dec 31, 2013 | -1.98 Mn |
| Sep 30, 2013 | -2.58 Mn |
| Jun 30, 2013 | -3.79 Mn |
| Mar 31, 2013 | -3.52 Mn |